LGALS9 and cancer: In contrast, galectin-9 tends to evoke an anti-inflammatory response, rendering it a promising intervention in the treatment of autoimmune and inflammatory conditions such as intracerebral hemorrhage [49], cancer [50], allograft rejection [51], and chronic asthma [52].